NCT05990491

Brief Summary

Prolonged circulatory shock is associated with marked disturbances in vascular supply to the brain, and endothelial dysfunction which can lead to disseminated intravascular coagulation and microvascular thrombosis. Pituitary dysfunction is documented following post-partum hemorrhage, traumatic brain injury and subarachnoid hemorrhage, which also affect blood flow to the pituitary. However, there are no studies assessing pituitary function in the aftermath of recovery from shock. This will be a prospective observational study of patients admitted in Critical Care Medicine (CCM) ICU who have recovered from prolonged septic shock (Lasting for a period of \> 24 hours). Blood samples of the participants will be estimated at the time of discharge from the ICU and at 6 months post discharge. Investigators will estimate fasting serum cortisol, TSH, Free T4, Testosterone (in males), Oestrogen (in females), LH, FSH, Prolactin, IGF-1 and plasma ACTH in all participants at both time points (at the time of ICU discharge and at 6-months follow-up). Participants who have borderline serum cortisol values (138-400 nmol/l) will be subjected to 250ug ACTH stimulation test. Expected outcome of the proposed study is to know proportion of patients having pituitary hormone axis dysfunction. Investigators will also look for pituitary dysfunction persist or revert, or there are new onset dysfunction at 6 month follow up. This would have major implications in the follow up and management of ICU survivors.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
90

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Aug 2023

Geographic Reach
1 country

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 30, 2023

Completed
15 days until next milestone

First Posted

Study publicly available on registry

August 14, 2023

Completed
14 days until next milestone

Study Start

First participant enrolled

August 28, 2023

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2025

Completed
Last Updated

October 15, 2024

Status Verified

October 1, 2024

Enrollment Period

1.9 years

First QC Date

July 30, 2023

Last Update Submit

October 9, 2024

Conditions

Keywords

Septic shockPost intensive care syndromeHypopituitarism

Outcome Measures

Primary Outcomes (1)

  • Pituitary dysfunction at discharge

    Frequency of dysfunction of various hypothalamo-pituitary hormone axes

    Immediately before the ICU discharge

Secondary Outcomes (1)

  • Pituitary dysfunction at 6 months

    Six months after the ICU discharge

Study Arms (2)

Septic shock group

Patients 18-80 years of age who meet the definition of septic shock. Vasopressor requirement should be maintained for a period \>24 hours and should require ICU stay for a duration of \> 7 days. Patient should recover from shock and be planned for discharge from the ICU.

Non-septic shock group

Patients 18-80 years of age who planned for discharge from the ICU.with stay for a duration of \>7 days. Also, they should not have received vasopressor for.a period of \>24 hours

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Consecutive patients admitted to critical care medicine intensive care unit at Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow who meet the inclusion and exclusion criteria

You may qualify if:

  • Septic shock group:
  • Patients 18-80 years of age who meet the definition of septic shock.
  • Vasopressor requirement should be maintained for a period \> 24 hours and should require ICU stay for a duration of \> 7 days.
  • Patient should recover from shock and be planned for discharge from the ICU
  • Non-septic shock group
  • Patients 18-80 years of age who planned for discharge from the ICU.with stay for a duration of \>7 days.
  • Also, they should not have received vasopressor for.a period of \>24 hours

You may not qualify if:

  • Patients who refuse to provide consent.
  • Age \<18 years or \> 80 years of age.
  • Pregnancy or immediate post-partum (\< 6 months post-delivery).
  • Chronic kidney disease (Stage 5), chronic liver disease (CHILD B or C), severe Chronic obstructive pulmonary disease, Chronic heart failure.
  • Patients with pre-existing hypopituitarism on replacement.
  • Past history of severe post-partum hemorrhage requiring blood transfusion, traumatic brain injury, subarachnoid hemorrhage, pituitary tumor/surgery, snake bite envenomation and meningo-encephalitis.
  • Patients who have been on \> 5 mg prednisolone equivalent for a period of more than 2 weeks at any time in the previous 6 months before admission.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Department of Critical Care Medicine, SGPGIMS

Lucknow, Uttar Pradesh, 226014, India

RECRUITING

Department of Endocrinology, SGPGIMS

Lucknow, Uttar Pradesh, 226014, India

RECRUITING

Biospecimen

Retention: SAMPLES WITH DNA

Blood samples (8-10 ml) collected at the time of recruitment and at 6 months follow-up.

MeSH Terms

Conditions

Shock, SepticHypopituitarismpostintensive care syndrome

Condition Hierarchy (Ancestors)

SepsisInfectionsSystemic Inflammatory Response SyndromeInflammationPathologic ProcessesPathological Conditions, Signs and SymptomsShockPituitary DiseasesHypothalamic DiseasesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesEndocrine System Diseases

Study Officials

  • Subhash Yadav

    Sanjay Gandhi Postgraduate Institute of Medical Sciences

    PRINCIPAL INVESTIGATOR
  • Mohan Gurjar

    Sanjay Gandhi Postgraduate Institute of Medical Sciences

    PRINCIPAL INVESTIGATOR
  • Jayakrishnan C, DM

    Sanjay Gandhi Postgraduate Institute of Medical Sciences

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Jayakrishnan C, DM

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

July 30, 2023

First Posted

August 14, 2023

Study Start

August 28, 2023

Primary Completion

August 1, 2025

Study Completion

August 1, 2025

Last Updated

October 15, 2024

Record last verified: 2024-10

Data Sharing

IPD Sharing
Will not share

Locations